Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients

Diabetes Metab J 2013;37:36-39 The Efficacy of Vildagliptin in Korean Patients with Type 2 Diabetes

Jun Sung Moon
Kyu Chang Won

August 2016

This is an Open Access article distributed under the terms of the Creative Commons At

ORIGINAL RESEARCH Efficacy and Safety of a Single-Pill Combination of Vildagliptin and Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized,

Double-blind Placebo-controlled Trial
Masato Odawara
Mika Yoshiki
Misako Sano
Izumi Hamada
Valentina Lukashevich
Wolfgang Kothny

August 2016

The Author(s) 2015. This article is published with open access at Springerlink.com Introduction: The...

Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin

Schwartz SS
Katz A

March 2016

Stanley S Schwartz,1,2 Arie Katz3 1University of Pennsylvania, Philadelphia, PA, USA; 2Main Line Hea...

Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients

강은석
송선옥
윤유정
이병완
이영기
이현철
조용인
차봉수
김광준

January 2013

BACKGROUND: This study compared the glycemic effectiveness of three metformin-based dual therapies a...

Diabetes Metab J 2013;37:429-432 Metformin Based Dual-Combination Therapies in Drug Naïve Type 2 Diabetic Patients

Dong-lim Kim

August 2016

This is an Open Access article distributed under the terms of the Creative Commons At

Clinical utility of fixed combinations of sitagliptin–metformin in treatment of type 2 diabetes

Green J
Karen K
Cox ME

October 2010

Karen Barnard1,2, Mary Elizabeth Cox1, Jennifer B Green1,21Department of Medicine, Division of Endoc...

Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin

Bo Ahr&eacute

April 2008

Bo AhrénDepartment of Clinical Sciences, Division of Medicine, Lund University, Lund, SwedenA...

New combination treatments in the management of diabetes: focus on sitagliptin – metformin

Jennifer Green
Mark Feinglos

August 2008

Jennifer Green, Mark FeinglosDuke University Medical Center, Department of Medicine, Division of End...

Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus

Shannon A Miller
Erin L St Onge
J Roger Accardi

May 2009

Shannon A Miller1, Erin L St Onge2, J Roger Accardi31Pharmacotherapy Faculty, Florida Hospital East ...

Sitagliptin/metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy

Hayes J
Anderson R
Stephens JW

July 2016

Jennifer Hayes,1 Rosie Anderson,1 Jeffrey W Stephens1,2 1Department of Diabetes and Endocrinology, ...

Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus

Min Kyong Moon
Kyu-Yeon Hur
Seung-Hyun Ko
Seok-O Park
Byung-Wan Lee
Jin Hwa Kim
Sang Youl Rhee
Hyun Jin Kim
Kyung Mook Choi
Nan-Hee Kim

October 2017

The Korean Diabetes Association (KDA) recently updated the Clinical Practice Guidelines on antihyper...

Clinical utility in the treatment of type 2 diabetes with the saxagliptin/metformin fixed combination

Panagoulias GS
Doupis J

February 2014

George S Panagoulias,1 John Doupis2,3 11st Department of Propaedeutic and Internal Medicine, Athens ...

Comparative efficacy and safety of DPP-4 inhibitors and α-glucosidase inhibitors as add on therapy in type 2 diabetes

Sahai, Rajit
Sharma, Taruna
Dhasmana, Dilip C.
Kaeley, Nidhi

March 2018

Background: Diabetes mellitus (DM) is a spectrum of metabolic disorders as a consequence of differen...

Patient considerations and clinical utility of a fixed dose combination of saxagliptin/metformin in the treatment of type 2 diabetes

Maffioli P
Derosa G

June 2011

Giuseppe Derosa, Pamela MaffioliDepartment of Internal Medicine and Therapeutics, University of Pavi...

Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin.

Ahrén, Bo

January 2008

Inhibition of dipeptidyl peptidase-4 (DPP-4) as a novel therapy for type 2 diabetes is based on prev...

Diabetes Metab J 2013;37:36-39 The Efficacy of Vildagliptin in Korean Patients with Type 2 Diabetes

Jun Sung Moon
Kyu Chang Won

August 2016

This is an Open Access article distributed under the terms of the Creative Commons At

ORIGINAL RESEARCH Efficacy and Safety of a Single-Pill Combination of Vildagliptin and Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized,

Double-blind Placebo-controlled Trial
Masato Odawara
Mika Yoshiki
Misako Sano
Izumi Hamada
Valentina Lukashevich
Wolfgang Kothny

August 2016

The Author(s) 2015. This article is published with open access at Springerlink.com Introduction: The...

Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin

Schwartz SS
Katz A

March 2016

Stanley S Schwartz,1,2 Arie Katz3 1University of Pennsylvania, Philadelphia, PA, USA; 2Main Line Hea...

Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients

강은석
송선옥
윤유정
이병완
이영기
이현철
조용인
차봉수
김광준

January 2013

BACKGROUND: This study compared the glycemic effectiveness of three metformin-based dual therapies a...

Diabetes Metab J 2013;37:429-432 Metformin Based Dual-Combination Therapies in Drug Naïve Type 2 Diabetic Patients

Dong-lim Kim

August 2016

This is an Open Access article distributed under the terms of the Creative Commons At

Clinical utility of fixed combinations of sitagliptin–metformin in treatment of type 2 diabetes

Green J
Karen K
Cox ME

October 2010

Karen Barnard1,2, Mary Elizabeth Cox1, Jennifer B Green1,21Department of Medicine, Division of Endoc...

Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin

Bo Ahr&eacute

April 2008

Bo AhrénDepartment of Clinical Sciences, Division of Medicine, Lund University, Lund, SwedenA...

New combination treatments in the management of diabetes: focus on sitagliptin – metformin

Jennifer Green
Mark Feinglos

August 2008

Jennifer Green, Mark FeinglosDuke University Medical Center, Department of Medicine, Division of End...

Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus

Shannon A Miller
Erin L St Onge
J Roger Accardi

May 2009

Shannon A Miller1, Erin L St Onge2, J Roger Accardi31Pharmacotherapy Faculty, Florida Hospital East ...

Sitagliptin/metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy

Hayes J
Anderson R
Stephens JW

July 2016

Jennifer Hayes,1 Rosie Anderson,1 Jeffrey W Stephens1,2 1Department of Diabetes and Endocrinology, ...

Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus

Min Kyong Moon
Kyu-Yeon Hur
Seung-Hyun Ko
Seok-O Park
Byung-Wan Lee
Jin Hwa Kim
Sang Youl Rhee
Hyun Jin Kim
Kyung Mook Choi
Nan-Hee Kim

October 2017

The Korean Diabetes Association (KDA) recently updated the Clinical Practice Guidelines on antihyper...

Clinical utility in the treatment of type 2 diabetes with the saxagliptin/metformin fixed combination

Panagoulias GS
Doupis J

February 2014

George S Panagoulias,1 John Doupis2,3 11st Department of Propaedeutic and Internal Medicine, Athens ...

Comparative efficacy and safety of DPP-4 inhibitors and α-glucosidase inhibitors as add on therapy in type 2 diabetes

Sahai, Rajit
Sharma, Taruna
Dhasmana, Dilip C.
Kaeley, Nidhi

March 2018

Background: Diabetes mellitus (DM) is a spectrum of metabolic disorders as a consequence of differen...

Patient considerations and clinical utility of a fixed dose combination of saxagliptin/metformin in the treatment of type 2 diabetes

Maffioli P
Derosa G

June 2011

Giuseppe Derosa, Pamela MaffioliDepartment of Internal Medicine and Therapeutics, University of Pavi...

Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin.

Ahrén, Bo

January 2008

Inhibition of dipeptidyl peptidase-4 (DPP-4) as a novel therapy for type 2 diabetes is based on prev...

Diabetes Metab J 2013;37:36-39 The Efficacy of Vildagliptin in Korean Patients with Type 2 Diabetes

Jun Sung Moon
Kyu Chang Won

August 2016

This is an Open Access article distributed under the terms of the Creative Commons At

ORIGINAL RESEARCH Efficacy and Safety of a Single-Pill Combination of Vildagliptin and Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized,

Double-blind Placebo-controlled Trial
Masato Odawara
Mika Yoshiki
Misako Sano
Izumi Hamada
Valentina Lukashevich
Wolfgang Kothny

August 2016

The Author(s) 2015. This article is published with open access at Springerlink.com Introduction: The...

Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin

Schwartz SS
Katz A

March 2016

Stanley S Schwartz,1,2 Arie Katz3 1University of Pennsylvania, Philadelphia, PA, USA; 2Main Line Hea...

Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients

Abstract

Extracted data

Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients

Abstract

Extracted data

Related items

Related items